Strategy Asset Managers LLC Eli Lilly & CO Transaction History

Strategy Asset Managers LLC

$518 Million
Q3 2024

A detailed history of Strategy Asset Managers LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Strategy Asset Managers LLC holds 15,929 shares of LLY stock, worth $12.6 Million. This represents 2.72% of its overall portfolio holdings.

Number of Shares

15,929

Previous 6,838 132.95%

Holding current value

$12.6 Million

Previous $6.19 Million 127.98%

% of portfolio

2.72%

Previous 1.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$772.14 - $960.02 $7.02 Million - $8.73 Million	9,091 Added 132.95%	15,929 $14.1 Million
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $6.2 Million - $7.78 Million	-8,558 Reduced 55.59%	6,838 $6.19 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $158,117 - $211,538	267 Added 1.76%	15,396 $12 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $4.67 Million - $5.5 Million	8,883 Added 142.22%	15,129 $8.82 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $257,342 - $354,785	-592 Reduced 8.66%	6,246 $3.35 Million
Q2 2023 Aug 24, 2023	BUY	$350.74 - $468.98 $13,678 - $18,290	39 Added 0.57%	6,838 $3.21 Million
Q1 2023 May 02, 2023	BUY	$310.63 - $364.82 $5,901 - $6,931	19 Added 0.28%	6,799 $2.33 Million
Q4 2022 Jan 13, 2023	SELL	$321.55 - $374.67 $26,045 - $30,348	-81 Reduced 1.18%	6,780 $2.48 Million
Q3 2022 Oct 11, 2022	BUY	$296.48 - $337.87 $791,305 - $901,775	2,669 Added 63.67%	6,861 $2.22 Million
Q2 2022 Jul 13, 2022	SELL	$278.73 - $327.27 $2,229 - $2,618	-8 Reduced 0.19%	4,192 $1.36 Million
Q1 2022 Apr 11, 2022	BUY	$234.69 - $291.66 $160,997 - $200,078	686 Added 19.52%	4,200 $1.2 Million
Q4 2021 Jan 14, 2022	SELL	$224.85 - $279.04 $154,247 - $191,421	-686 Reduced 16.33%	3,514 $971,000
Q3 2021 Dec 14, 2021	BUY	$221.6 - $272.71 $152,017 - $187,079	686 Added 19.52%	4,200 $970,000
Q2 2021 Aug 04, 2021	SELL	$180.55 - $233.54 $265,408 - $343,303	-1,470 Reduced 29.49%	3,514 $807,000
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $580,871 - $751,965	-3,535 Reduced 41.5%	4,984 $931,000
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $112,326 - $148,634	-861 Reduced 9.18%	8,519 $1.44 Million
Q3 2020 Nov 03, 2020	BUY	$146.22 - $169.13 $584,002 - $675,505	3,994 Added 74.16%	9,380 $1.39 Million
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $54,295 - $65,343	398 Added 7.98%	5,386 $884,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $595,964 - $737,634	-5,006 Reduced 50.09%	4,988 $692,000
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $104,995 - $130,046	982 Added 10.9%	9,994 $1.31 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $26,590 - $28,923	249 Added 2.84%	9,012 $1.01 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.45 Million - $1.7 Million	-13,118 Reduced 59.95%	8,763 $971,000
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $2.12 Million - $2.5 Million	19,072 Added 678.96%	21,881 $2.84 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $13,767 - $15,423	130 Added 4.85%	2,809 $325,000
Q2 2018 Aug 07, 2018	BUY	$75.7 - $86.88 $202,800 - $232,751	2,679 New	2,679 $229,000
Q1 2018 May 03, 2018	SELL	$74.21 - $87.6 $198,808 - $234,680	-2,679 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	2,679	2,679 $220,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.

Account

Strategy Asset Managers LLC Eli Lilly & CO Transaction History